CERo Therapeutics Holdings (CERo Therapeutics Holdings) Price-to-Tangible-Book : (As of May. 26, 2024)

View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Price-to-Tangible-Book?

As of today (2024-05-26), CERo Therapeutics Holdings's share price is $0.9178. CERo Therapeutics Holdings's Tangible Book per Share of Dec. 2022 for the quarter that ended in Dec. 2022 was $-3.39. Hence, CERo Therapeutics Holdings's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for CERo Therapeutics Holdings's Price-to-Tangible-Book or its related term are showing as below:

CERO's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.79
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, CERo Therapeutics Holdings's share price is $0.9178. CERo Therapeutics Holdings's Book Value per Sharefor the quarter that ended in Dec. 2022 was $-3.39. Hence, CERo Therapeutics Holdings's P/B Ratio of today is .

CERo Therapeutics Holdings Price-to-Tangible-Book Historical Data

The historical data trend for CERo Therapeutics Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Price-to-Tangible-Book Chart

CERo Therapeutics Holdings Annual Data

Trend

Dec21

Dec22

Price-to-Tangible-Book

CERo Therapeutics Holdings Semi-Annual Data
	Dec21	Dec22
Price-to-Tangible-Book	-	-

Competitive Comparison of CERo Therapeutics Holdings's Price-to-Tangible-Book

For the Biotechnology subindustry, CERo Therapeutics Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CERo Therapeutics Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CERo Therapeutics Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where CERo Therapeutics Holdings's Price-to-Tangible-Book falls into.

CERo Therapeutics Holdings Price-to-Tangible-Book Calculation

CERo Therapeutics Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2022 )
	=	0.9178	/	-3.388
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

CERo Therapeutics Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080

Website

https://www.cero.bio

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024